1.
Staying ahead of dupilumab-associated ocular surface disease. Can Dermatol Today [Internet]. 2022 Sep. 1 [cited 2026 Mar. 19];3(3):26–34. Available from: https://canadiandermatologytoday.com/article/view/3-3-laughrea-hebert